21 Partners' Almaviva Sante acquires two French clinics
Almaviva Sante, portfolio company of 21 Partners, has acquired French private healthcare clinics Axium and Clinique Toutes Aures.
Société Générale, OBC Neuflize and Caisse d'Epargne Provence Alpes Corse provided a senior debt package for the acquisition. Société Générale also provided mezzanine funding, advised by Hogan Lovells.
Follwing the acquisition, Almaviva Sante will have an 800-bed capacity, allowing it to perform up to 800,000 surgeries per year. The expected turnover of the consolidated group in 2012 is €100m.
Almaviva has acquired seven clinics since it was first bought by 21 Partners in June 2007 for less than €25m.
Company
Axium is a clinic in Aix en Provence that provides a range of surgical and other medical services. Its expertise include cardiology, ophtalmology, surgery and others. The clinic's 2011 turnover was €23m, with 22,000 patients treated.
Clinique Toutes Aures is based in Manosque and works in collaboration with Axium. In 2011, it registered 6,000 treatments with a turnover of €4m.
People
Senior associate Henry Huyghues Despointes led the deal on behalf of 21 Partners.
Advisers
Equity – HPML, Vincent Libaud, Marie-Laure Pichard (Legal); Lefaure Bouchony (Legal); Ernst & Young, François Rochmann, Chloé Launois (Financial due diligence); Audit Chorus Conseil (Assurance); ERM (Environmental due diligence); Socotec (Real estate due diligence).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds








